Filing Details

Accession Number:
0000950170-23-065868
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-22 16:05:11
Reporting Period:
2023-11-20
Accepted Time:
2023-11-22 16:05:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1745999 Beam Therapeutics Inc. BEAM Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1963878 Christine Bellon C/O Beam Therapeutics Inc.,
238 Main Street
Cambridge MA 02142
Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-20 4,182 $7.22 86,584 No 4 M Direct
Common Stock Acquisiton 2023-11-20 5,818 $7.22 92,402 No 4 M Direct
Common Stock Disposition 2023-11-20 5,000 $30.00 87,402 No 4 S Direct
Common Stock Disposition 2023-11-20 5,000 $31.00 82,402 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-11-20 4,182 $0.00 4,182 $7.22
Common Stock Stock Option (Right to Buy) Disposition 2023-11-20 5,818 $0.00 5,818 $7.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,492 2029-05-16 No 4 M Direct
10,918 2029-05-17 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
  2. The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
  3. The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.